SVT-15473 - Post surgery ocular inflammation and pain - Ophthalmic nanoemulsion Rx

Product description

First Ophthalmic ultra high potency corticosteroid in unit dose vials with wide protection patent, formulated in nanoemulsion (nanodroplets below 50nm), using a patented drug delivery technology. Post surgery ocular inflammation and pain. On going Phase III
Salvat’s Nanoemulsion Drug Delivery Technology addresses limitations of existing therapies that have less than optimal efficacy or unfavorable side effects as a result of formulation, pharmacokinetic profiles or other complexities

Read more

Specifications

Categories Finished Dosage FormsDrops; Finished Dosage Forms
Sales markets Middle East Region (e.g. UAE); North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Spain

More products from Laboratorios Salvat, S.A.

View all our products (21)

Products from other suppliers